Ethyl isocyanate → HCID 131732949, compound
Reaction equation
[Si]([O:8][CH2:9][C:10]1[C:11]([F:30])=[C:12]([C:16]2[CH:17]=[N:18][C:19]([O:22][CH2:23][CH:24]3[CH2:29][CH2:28][NH:27][CH2:26][CH2:25]3)=[N:20][CH:21]=2)[CH:13]=[CH:14][CH:15]=1)(C(C)(C)C)(C)C.[CH2:31]1[CH2:35][O:34]CC1.[CH2:36]([N:38]=C=O)[CH3:37].CCCC[N+](CCCC)(CCCC)CCCC.[F-].C1COCC1>CCOC(C)=O.O>[CH2:36]([NH:38][C:35]([CH2:31][N:27]1[CH2:26][CH2:25][CH:24]([CH2:23][O:22][C:19]2[N:18]=[CH:17][C:16]([C:12]3[CH:13]=[CH:14][CH:15]=[C:10]([CH2:9][OH:8])[C:11]=3[F:30])=[CH:21][N:20]=2)[CH2:29][CH2:28]1)=[O:34])[CH3:37]Participants
7
Procedure
5-[3-({[tert-Butyl(dimethyl)silyl]oxy}methyl)-2-fluorophenyl]-2-(piperidin-4-ylmethoxy)pyrimidine (200 mg) was mixed with THF (4 ml), and ethylisocyanate (91 mg) was added thereto, followed by stirring at room temperature overnight. A 1M TBAF/THF solution (1 ml) was added to the reaction mixture, followed by further stirring at room temperature for 3 hours. Water and EtOAc were added to the reaction mixture, and the organic layer was dried over Na2SO4 and concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (MeOH/CHCl3) to obtain N-ethyl-4-[({5-[2-fluoro-3-(hydroxymethyl)phenyl]pyrimidin-2-yl}oxy)methyl]piperidine-1-carboxyamide (159.3 mg).
Workup
- additionwas added
- stirringby further stirring at room temperature for 3 hours
- dry with materialthe organic layer was dried over Na2SO4
- concentrationconcentrated under reduced pressure
- customThe obtained residue was purified by silica gel column chromatography (MeOH/CHCl3)
Sources & evidence
- ORD record
- ord-60e03362e2a64fdd92d3039c6007f1a0
- Source dataset
- uspto-grants-2015_06
- Patent number
- US09051283B2
Reaction notes
Loading…